人工智能用于甲状腺结节评估:入门指南
本文综述人工智能在甲状腺结节评估中的应用,涵盖机器学习与深度学习两种技术,指出多数平台聚焦结节恶性风险分层,已有四种获美国食品药品监督管理局批准,验证研究结果不一,但充分证据表明人工智能可超越部分人类尤其是经验较少医生的表现,并已应用于淋巴结和细胞病理标本评估。
要点
- 人工智能包括机器学习与深度学习,后者用神经网络模拟脑结构与功能分析数据。
- 多数甲状腺疾病人工智能平台聚焦结节恶性风险分层,已有四种获美国食品药品监督管理局批准。
- 验证研究结果不一,但充分证据表明人工智能可超越部分人类尤其是经验较少医生的表现。
核心结论
- 人工智能在甲状腺疾病中的采用需要供应商证明其软件按预期工作、在真实环境中易用且具有成本效益,头对头比较中表现最佳的平台将主导并推动更广泛采用。
研究设计与样本
- 本文为综述,聚焦人工智能在甲状腺结节评估中的应用。
主要发现
- 人工智能涵盖机器学习(计算机通过观察人类提供的数据学习)和深度学习(采用模拟脑结构与功能的神经网络分析数据)两种计算技术。
- 一些专家认为人工智能系统得出结论的方式应透明或可解释,而另一些专家不同意。
- 多数甲状腺疾病人工智能平台聚焦结节恶性风险分层,截至本文已有四种获美国食品药品监督管理局批准。
- 验证研究结果不一,但有充分证据表明人工智能可超越部分人类尤其是经验较少医生的表现。
- 人工智能也已应用于淋巴结评估和细胞病理标本评估。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Artificial intelligence (AI) is broadly defined as the ability of machines to apply human-like reasoning to problem solving. Recent years have seen a rapid growth of AI in many disciplines. This review will focus on AI applications in the assessment of thyroid nodules. Summary: AI encompasses two related computational techniques: machine learning, in which computers learn by observing data provided by humans, and deep learning, which employs neural networks that mimic brain structure and function to analyze data. Some experts believe the way AI systems reach a conclusion should be transparent, or explainable, while others disagree. Most AI platforms in thyroid disease have focused on malignancy risk stratification of nodules. To date, four have been approved by the United States Food and Drug Administration. While the results of validation studies have been mixed, there is ample evidence that AI can exceed the performance of some humans, particularly physicians with less experience. AI has also been applied to assessment of lymph nodes and cytopathology specimens. Conclusions: Adoption of AI in thyroid disease will require vendors to demonstrate that their software works as intended, is readily usable in real-world settings, and is cost effective. AI platforms that perform best in head-to-head comparisons will dominate and spur wider adoption.
引用
- Tessler FN, Thomas J. Artificial Intelligence for Evaluation of Thyroid Nodules: A Primer. Thyroid. 2023. PMID: 36424829. doi:10.1089/thy.2022.0560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。